Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED
Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Aimmune Therap

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Uptrend Call Working As Aimmune Therapeu Stock Rises 27.6% (AIMT)
SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 3 months, Aimmune Therapeu has returned 27.58% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Benzinga's Top Upgrades, Downgrades For December 19, 2019
Upgrades Stephens & Co. upgraded the stock for Byline Bancorp Inc (NYSE: BY) from Equal-Weight to Overweight. For the third ... 
Tags EC KRTX Intraday Update
From Benzinga
Cramer Gives His Opinion On Synopsys, Cisco And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Synopsys, Inc. (NASDAQ: SNPS) is a buy. He thinks the company is ... 
Tags VTR CARA Jim Cramer
From Benzinga
4 Healthcare Stocks With FDA Approvals on the Horizon
With FDA approval deadlines approaching in 2020, these four drug developers could see substantial gains if they're successful. 
Tags ESPR AIMT Market News
From Motley Fool
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags SNY AIMT VERU
From Benzinga
Aimmune Therapeu Has Returned 29.9% Since SmarTrend Recommendation (AIMT)
SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 3 months, Aimmune Therapeu has returned 29.92% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Stocks That Hit 52-Week Highs On Wednesday
Wednesday's morning session saw 173 companies set new 52-week highs. Noteables: Apple (NASDAQ: AAPL) was the company with ... 
Tags SNY AIMT ALCO
From Benzinga
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags IMMU CORV Top Stories
From Benzinga
Notable Tuesday Option Activity: IIPR, LPI, AIMT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Innovative Industrial Properties Inc (IIPR), where a total of 2,576 contracts have traded so... 
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was ... 
Tags MSD CUBA ATAZF
From Benzinga
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week ... 
Tags EQ XLRN EPZM
From Benzinga
Stocks That Hit 52-Week Highs On Friday
This morning 257 companies set new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week ... 
Tags IBTX MDU HBAN
From Benzinga
February 2020 Options Now Available For Aimmune Therapeutics (AIMT)
Investors in Aimmune Therapeutics Inc (AIMT) saw new options begin trading today, for the February 2020 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
Notable Monday Option Activity: RRD, NPTN, AIMT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Donnelley & Sons Company (RRD), where a total of 3,030 contracts have traded so far,... 
Tags Stocks
From Market News Video
Aimmune Therapeu Shares Up 7.2% Since SmarTrend's Buy Recommendation (AIMT)
SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 2 months, Aimmune Therapeu has returned 7.24% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Stocks Showing Market Leadership: Aimmune Therapeutics Earns 91 RS Rating
Aimmune Therapeutics sees its Relative Strength Rating enter the elite 90-plus level. 
From Investor's Business Daily
First Week of AIMT January 2020 Options Trading
Investors in Aimmune Therapeutics Inc (AIMT) saw new options begin trading this week, for the January 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AIMT... 
Tags Stocks
From Market News Video
Peek Under The Hood: VBK Has 12% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy Wednesday Option Activity: IBM, HON, AIMT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in International Business Machines Corp (IBM), where a total of 29,019 contracts have traded so... 
Tags Stocks
From Market News Video
20 Stocks That Could Double Your Money in 2020
Big gains could be just a click of the buy button away. 
Tags PING AIMT AM
From Motley Fool
Aimmune Therapeutics Inc (AIMT) Q3 2019 Earnings Call Transcript
AIMT earnings call for the period ending September 30, 2019. 
Tags AIMT Market News
From Motley Fool
The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags XLRN ALBO GLMD
From Benzinga
Aimmune CFO On Peanut Allergy Candidate Palforzia: 'There Is A Serious Unmet Need'
A novel oral immunotherapy developed by Aimmune Therapeutics Inc (NASDAQ: AIMT) to treat peanut allergy is on the cusp of FDA approval ... 
Tags Interview Biotech Trading Ideas
From Benzinga
17.8% Return Seen to Date on SmarTrend Aimmune Therapeu Call (AIMT)
SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 2 months, Aimmune Therapeu has returned 17.83% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight
Biotech stocks extended their gains last week amid earnings news flow and the broader market strength. Large-cap pharma stocks saw ... 
Tags VIR Market News HZNP
From Benzinga
Najarian Brothers Highlight Unusual Options Activity In Activision Blizzard, Cronos Group
On CNBC's "Fast Money Halftime Report," Pete Najarian spoke about unusual options activity in Activision Blizzard, Inc. ... 
Tags Options AIMT ATVI
From Benzinga
The Math Shows IWO Can Go To $241
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stock Upgrades: Aimmune Therapeutics Shows Rising Relative Strength
Aimmune Therapeutics sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
Stocks Generating Improved Relative Strength: Aimmune Therapeutics
A Relative Strength Rating upgrade for Aimmune Therapeutics shows improving technical performance. Will it continue? 
From Investor's Business Daily
46 Biggest Movers From Yesterday
Gainers The Stars Group Inc. (NASDAQ: TSG) shares climbed 30.1% to close at $19.91 on Wednesday after the company announced an ... 
Tags Human Resource & Employment Services GORO OCGN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback